COMPASS Pathways plc(CMPS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CMPS COMPASS Pathways plc

Closed 02-19 16:00:00 EST

8.26

-0.19

-2.25%

盘后8.33

+0.07+0.85%

19:58 EST

High8.52	Low7.71	Vol14.80M
Open8.51	D1 Closing8.45	Amplitude9.59%
Mkt Cap793.10M	Tradable Cap482.50M	Total Shares96.02M
T/O120.28M	T/O Rate25.34%	Tradable Shares58.41M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CMPS","market":"US","secType":"STK","nameCN":"COMPASS Pathways plc","latestPrice":8.26,"timestamp":1771534800000,"preClose":8.45,"halted":0,"volume":14803777,"hourTrading":{"tag":"盘后","latestPrice":8.33,"preClose":8.26,"latestTime":"19:58 EST","volume":155612,"amount":1286534.8001,"timestamp":1771549119893,"change":0.07,"changeRate":0.008475,"amplitude":0.013317},"delay":0,"changeRate":-0.02248520710059166,"floatShares":58414107,"shares":96017044,"eps":-2.73668,"marketStatus":"Closed","change":-0.19,"latestTime":"02-19 16:00:00 EST","open":8.51,"high":8.52,"low":7.71,"amount":120275521.606827,"amplitude":0.095858,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.73668,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771578000000},"marketStatusCode":5,"adr":0,"adrRate":1,"listingDate":1600401600000,"exchange":"NASDAQ","adjPreClose":8.45,"preHourTrading":{"tag":"盘前","latestPrice":8.5,"preClose":8.45,"latestTime":"09:29 EST","volume":564733,"amount":4857003.10849,"timestamp":1771511380094,"change":0.05,"changeRate":0.005917,"amplitude":0.107692},"postHourTrading":{"tag":"盘后","latestPrice":8.33,"preClose":8.26,"latestTime":"19:58 EST","volume":155612,"amount":1286534.8001,"timestamp":1771549119893,"change":0.07,"changeRate":0.008475,"amplitude":0.013317},"volumeRatio":1.579763,"optionData":{"bulkOrders":[{"symbol":"CMPS","call":false,"expireDate":1776398400000,"strike":"8.0","timestamp":1771519724249,"price":1.1,"volume":1575,"amount":173250,"type":"-"},{"symbol":"CMPS","call":false,"expireDate":1776398400000,"strike":"8.0","timestamp":1771519724115,"price":1.1,"volume":1182,"amount":130020,"type":"-"}]},"impliedVol":1.0561,"impliedVolPercentile":0.2072},"requestUrl":"/m/hq/s/CMPS/wiki","defaultTab":"wiki","newsList":[{"id":"2612832782","title":"Compass Pathways Shares Reverse Premarket Course; Last Down 4.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612832782","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612832782?lang=en_us&edition=fundamental","pubTime":"2026-02-19 22:32","pubTimestamp":1771511574,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nFWN3ZF0IF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMPS","BK4139"],"gpt_icon":0},{"id":"2612407525","title":"Shares of Compass Pathways up 2.6% Premarket After Co Announces $150 Mln Equity Raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2612407525","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612407525?lang=en_us&edition=fundamental","pubTime":"2026-02-19 20:40","pubTimestamp":1771504847,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nL6N3ZF0OV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMPS","BK4139"],"gpt_icon":0},{"id":"2612407890","title":"BUZZ-Compass Pathways climbs premarket after $150 mln equity raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2612407890","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612407890?lang=en_us&edition=fundamental","pubTime":"2026-02-19 20:34","pubTimestamp":1771504481,"startTime":"0","endTime":"0","summary":"** Compass Pathways CMPS.O shares up 2.8% premarket at $8.69 after $150 mln follow-on offering priced. ** UK-based biotech late Weds sold 18.75 mln American depositary shares, including 1.25 mln pre-funded warrants, at. ** Co intends to use net offering proceeds to fund ongoing COMP005 and COMP006 Phase 3 trials, Phase 2b/3 trial of COMP360 in post-traumatic stress disorder, among other purposes. ** CMPS shares on Tues soared 31% after co said its psilocybin-based therapy, COMP360, eased depression symptoms in late-stage trial, as it aims to win approval for the first classic psychedelic treatment in the US. ** Jefferies, TD Cowen, Cantor Fitzgerald and Stifel joint bookrunners for the offering. ** Through Weds, CMPS shares up about 90% over the past 12 months. ** Avg rating of 11 analysts is \"buy\"; median PT $20, per LSEG data","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nL6N3ZF0NU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SF","BK4139","CMPS","BK4127"],"gpt_icon":0},{"id":"2612037394","title":"Compass Pathways Prices $150 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2612037394","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612037394?lang=en_us&edition=fundamental","pubTime":"2026-02-19 17:08","pubTimestamp":1771492096,"startTime":"0","endTime":"0","summary":"Compass Pathways  said Wednesday it has priced a public offering of 17.5 million American depositary shares at $8 per share for gross proceeds of $150 million.The company said it is also offering institutional investors pre-funded warrants to purchase up to 1.3 million depositary shares at $7.9999 each.In addition, the company said it has granted the underwriters a 30-day option to purchase up to about 2.8 million additional depositary shares.The offering is expected to close around Friday.The company said it intends to use net proceeds from the offering, along with cash to fund ongoing clinical trials and for general corporate purposes.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CMPS"],"gpt_icon":0},{"id":"2612734164","title":"BRIEF-Compass Pathways Announces Pricing Of $150 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2612734164","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612734164?lang=en_us&edition=fundamental","pubTime":"2026-02-19 09:19","pubTimestamp":1771463943,"startTime":"0","endTime":"0","summary":"BRIEF-Compass Pathways Announces Pricing Of $150 Million Public OfferingFeb 18 (Reuters) - Compass Pathways PLC CMPS.O:COMPASS PATHWAYS ANNOUNCES PRICING OF $150 MILLION PUBLIC OFFERINGCOMPASS PATHWAY","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nTUA9QDSVY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPS"],"gpt_icon":0},{"id":"2612473970","title":"Compass Pathways Plc - Prices Public Offering of 17.5 Mln Ads at $8.00 per Ads","url":"https://stock-news.laohu8.com/highlight/detail?id=2612473970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612473970?lang=en_us&edition=fundamental","pubTime":"2026-02-19 09:18","pubTimestamp":1771463880,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nTUA9QDSVY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CMPS"],"gpt_icon":0},{"id":"2612252094","title":"Compass Pathways Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2612252094","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612252094?lang=en_us&edition=fundamental","pubTime":"2026-02-19 04:27","pubTimestamp":1771446420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CMPS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 18, 2026 15:27 ET (20:27 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","BK4139"],"gpt_icon":0},{"id":"2612428695","title":"Compass Pathways Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2612428695","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612428695?lang=en_us&edition=fundamental","pubTime":"2026-02-19 01:57","pubTimestamp":1771437420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CMPS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 18, 2026 12:57 ET (17:57 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","BK4139"],"gpt_icon":0},{"id":"2612702442","title":"European Equities Traded in the US as American Depositary Receipts Higher Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2612702442","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612702442?lang=en_us&edition=fundamental","pubTime":"2026-02-19 00:15","pubTimestamp":1771431312,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were rising on Wednesday morning, up 1.28% to 1,858.13 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by energy company Equinor  and semiconductor firm ASML , which rose 3.4% and 3.3% respectively. They were followed by clinical-stage biotech company Abivax  and bank Banco Santander , which added 2.9% and 2.5%, respectively.The decliners from continental Europe were led by clinical-stage biopharmaceutical company Agomab Therapeutics  and online shopping company LuxExperience , which fell 5.4% and 5.2%, respectively. They were followed by healthcare company Fresenius , which was down 2.6%.From the UK and Ireland, the gainers were led by pharmaceutical company Compass Pathways  and software development firm Endava , which gained 9.8% and 3.7% respectively.The decliners from the UK and Ireland were led by clinical diagnostic products provider Trinity Biotech  and pharmaceutical company Sil","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4196","BK4201","DAVA","BK7129","BK4094","SAN","ABVX","BK4588","LU0097036916.USD","03165","BK4134","AGMB","LU0345774631.USD","IE00BD6J9T35.USD","BK4521","BK4147","BK4082","LU0648005311.SGD","BK4139","BK4585","LU1734074674.USD","SLN","FMS","LU0084288595.USD","BK4117","IE0004445239.USD","BK7142","LU0823434740.USD","LU0823434583.USD","BK4207","EQNR","LUXE","LU0345774391.USD","LU2063271972.USD","ASML","BK4107","CMPS","TRIB","BK4543"],"gpt_icon":1},{"id":"2612442548","title":"BUZZ-Compass Pathways extends rally after psychedelic depression treatment's late-stage study win","url":"https://stock-news.laohu8.com/highlight/detail?id=2612442548","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612442548?lang=en_us&edition=fundamental","pubTime":"2026-02-18 23:45","pubTimestamp":1771429532,"startTime":"0","endTime":"0","summary":"** Compass Pathways CMPS.O shares up 14.9% to $8.77 and hit fresh one-year high on Weds, adding to big gain in prior session after its therapy helped patients with hard-to-treat form of depression. ** CMPS shares closed up 31% at $7.63 after co early Tues said its psilocybin-based therapy, COMP360, met main goal in late-stage trial as it aims to win approval for the first classic psychedelic treatment in the US. ** Subsequently, co late Tues launched $150 mln offering of American depositary shares. fund ongoing COMP005 and COMP006 Phase 3 trials, Phase 2b/3 trial of COMP360 in post-traumatic stress disorder, among other purposes, per the prospectus. ** Jefferies, TD Cowen, Cantor Fitzgerald and Stifel joint bookrunners. ** With the move on Weds, shares have roughly doubled over the past year. ** Avg rating of 11 analysts is \"buy\"; median PT of $20 up from $15 a month ago, per LSEG data","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nL6N3ZE0UQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","BK4139"],"gpt_icon":0},{"id":"2612498530","title":"Compass Pathways announces $150M American Depositary Shares offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2612498530","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612498530?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:15","pubTimestamp":1771362923,"startTime":"0","endTime":"0","summary":"Compass Pathways (CMPS) announced the launch of a proposed public offering of $150M of American Depositary Shares, or ADSs, each representing one o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/compass-pathways-announces-150m-american-depositary-shares-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/compass-pathways-announces-150m-american-depositary-shares-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMPS","BK4139","BK4107","BK4117","AFG"],"gpt_icon":0},{"id":"2612593460","title":"Compass Pathways Launches Proposed $150.0 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2612593460","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612593460?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:06","pubTimestamp":1771362360,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nTUA691Y6Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMPS","BK4139"],"gpt_icon":0},{"id":"2612898464","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2612898464","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612898464?lang=en_us&edition=fundamental","pubTime":"2026-02-18 02:39","pubTimestamp":1771353579,"startTime":"0","endTime":"0","summary":"The OLB Group  said Tuesday it entered into a global partner agreement with PayPal  to deliver a checkout and wallet experience for merchants across its ecosystem, including its SecurePay payment gateway.Shares of OLB almost tripled, with intraday trading volume catapulting to over 358.3 million from a daily average of about 214,000.Polaryx Therapeutics  said Tuesday it selected a contract research organization for the second phase of a trial evaluating the safety, tolerability, and clinical activity of PLX-200 across four lysosomal storage disorders.Shares surged 76% as intraday trading volume soared to over 46.5 million from a daily average of roughly 169,000.Compass Pathways  said Tuesday that a second phase 3 trial of COMP360 for treatment-resistant depression achieved its primary endpoint.Shares jumped 37%, with intraday trading volume at over 28.8 million compared with a daily average of about 1.4 million.Price: 1.24, Change: +0.82, Percent Change: +197.23","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OLB","BK4227","IE00BQXX3F31.USD","LU0106831901.USD","IE00BQXX3C00.GBP","LU1861220207.SGD","IE00BQXX3D17.EUR","BK4533","BK4554","PLYX","BK4598","BK4534","BK4007","LU1668664300.SGD","CMPS","BK4588","LU0158827948.USD","BK4535","LU1791807156.HKD","BK4585","PYPG","LU2360107671.USD","BK4581","BK4551","BK4106","LU2089283258.USD","LU2023251221.USD","BK4524","BK4527","BK4139","LU1861217088.USD","LU2089284900.SGD","PYPY","BK4566"],"gpt_icon":1},{"id":"2612465565","title":"Compass Pathways Plc : TD Cowen Raises Target Price to $29 From $23","url":"https://stock-news.laohu8.com/highlight/detail?id=2612465565","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612465565?lang=en_us&edition=fundamental","pubTime":"2026-02-17 23:46","pubTimestamp":1771343205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nFWN3ZD18J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMPS","BK4139"],"gpt_icon":0},{"id":"2612465141","title":"Robust Phase 3 Efficacy and Clean Safety Profile Drive Buy Rating on COMPASS Pathways’ CMPS","url":"https://stock-news.laohu8.com/highlight/detail?id=2612465141","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612465141?lang=en_us&edition=fundamental","pubTime":"2026-02-17 23:45","pubTimestamp":1771343123,"startTime":"0","endTime":"0","summary":"In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on COMPASS Pathways, with a price target of $29.00. Ritu Baral has giv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/robust-phase-3-efficacy-and-clean-safety-profile-drive-buy-rating-on-compass-pathways-cmps-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/robust-phase-3-efficacy-and-clean-safety-profile-drive-buy-rating-on-compass-pathways-cmps-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMPS"],"gpt_icon":0},{"id":"2612446586","title":"BUZZ-U.S. STOCKS ON THE MOVE-Ormat Technologies, Accenture, Kinsale Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2612446586","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612446586?lang=en_us&edition=fundamental","pubTime":"2026-02-17 23:40","pubTimestamp":1771342850,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Ormat Technologies, Accenture, Kinsale Capital Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Cal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nL6N3ZD0N1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBWI","ET","CVX","CNH","LU1061106388.HKD","WBD","LU1244550577.SGD","IE00B2Q91V27.USD","KD","ALB","CMPS","RIO","LU2211814178.USD","NCLH","GIS","DHR","GPC","CDE","BK4585","FISV","LU1721428347.USD","AVAV","SG9999001176.SGD","BK4107","LU1861217088.USD","LU0980610538.SGD","VMC","IE00BGHQF417.EUR","LU0130103400.USD","LU1804176565.USD","ACN","NEM","LU0312595415.SGD","LU2125910336.SGD","LU2462611646.USD","LU1791710582.SGD","IE00B19Z6F94.USD","KNSL","KW","ORA","LU2506951875.HKD","LU0788108826.HKD","IE00BQXX3D17.EUR","LU0055631609.USD","LU2063271972.USD","PSKY","LU0256331488.USD","HL","BK4548","COP"],"gpt_icon":0},{"id":"2612450062","title":"COMPASS Pathways Triumph In Hard To Treat Depression Ignites Investor Frenzy","url":"https://stock-news.laohu8.com/highlight/detail?id=2612450062","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612450062?lang=en_us&edition=fundamental","pubTime":"2026-02-17 22:12","pubTimestamp":1771337520,"startTime":"0","endTime":"0","summary":"Compass Pathways' stock surges after late-stage depression trial success.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/17/Agitated-Depression-Mentioned.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/17/Agitated-Depression-Mentioned.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/02/50650462/compass-pathways-triumph-in-hard-to-treat-depression-ignites-investor-frenzy","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/02/50650462/compass-pathways-triumph-in-hard-to-treat-depression-ignites-investor-frenzy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["IE00B19Z4B17.USD","IE00B7SZL793.SGD","CMPS","BK4139","BK4187","IE0031619046.USD","TGI","IE00B66KJ199.SGD"],"gpt_icon":0},{"id":"2612500914","title":"Analysts Conflicted on These Healthcare Names: Sensus Healthcare (SRTS), NeoGenomics (NEO) and COMPASS Pathways (CMPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2612500914","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612500914?lang=en_us&edition=fundamental","pubTime":"2026-02-17 22:10","pubTimestamp":1771337413,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sensus Healthcare (SRTS – Research Report), NeoGen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-sensus-healthcare-srts-neogenomics-neo-and-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-sensus-healthcare-srts-neogenomics-neo-and-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4588","CMPS","XLV","BK4585","LU0012050646.USD","NEO","BK4581","LU0106261612.USD","BK4196","BK4139","LABU","XBI","BK4082","SRTS"],"gpt_icon":0},{"id":"2612543234","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2612543234","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612543234?lang=en_us&edition=fundamental","pubTime":"2026-02-17 20:25","pubTimestamp":1771331140,"startTime":"0","endTime":"0","summary":"Tg-17  shares were 93% higher pre-bell Tuesday, rebounding from Friday's losses.ZIM Integrated Shipping Services  stock was up 35%, a day after the company said it has agreed to be acquired by Hapag-Lloyd in a deal worth about $4.2 billion.Masimo  shares were 34% higher after the Financial Times reported that Danaher  is close to acquiring the medical technology company in a deal worth $10 billion.Compass Pathways  stock was up past 23% after the company said that a second phase 3 trial of COMP360 for treatment-resistant depression achieved its primary endpoint.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2023250504.SGD","LU2125909247.SGD","LU0289960550.SGD","LU2106854487.HKD","LU0882574055.USD","LU0312595415.SGD","LU2244417387.USD","LU1974910355.USD","LU0205194284.USD","LU2355687059.USD","MASI","SG9999004303.SGD","LU0114720955.EUR","IE0004445239.USD","LU0320765059.SGD","IE00BQXX3C00.GBP","ZIM","DHR.AU","LU0390134368.USD","BK4533","DHR","LU1057294990.SGD","IE00BZ1G4Q59.USD","LU1267930730.SGD","LU1551013425.SGD","LU1804176565.USD","LU0157215616.USD","LU0122379950.USD","IE00BQXX3F31.USD","LU1061106388.HKD","BK4534","LU1551013342.USD","LU0528227936.USD","LU2720916845.USD","LU2764263203.CNY","LU1923621640.USD","LU0175139822.USD","LU1791710582.SGD","LU2265009873.SGD","SG9999013999.USD","IE000M9KFDE8.USD","LU1023059063.AUD","SGXZ57979304.SGD","CMPS","ZIM.AU","OBAI","LU0240877869.USD","BK4585","LU2063271972.USD","IE00BQXX3D17.EUR"],"gpt_icon":0},{"id":"2612459038","title":"Compass' psychedelic-based depression treatment scores second late-stage study win","url":"https://stock-news.laohu8.com/highlight/detail?id=2612459038","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612459038?lang=en_us&edition=fundamental","pubTime":"2026-02-17 19:59","pubTimestamp":1771329589,"startTime":"0","endTime":"0","summary":"UPDATE 3-Compass' psychedelic-based depression treatment scores second late-stage study winCOMP360 shows rapid symptom improvement in depression studyCOMP360 may compete with J&J's Spravato if approvedCompass plans FDA meeting for rolling submissionUpdates share move, adds CEO comment in paragraph 5, analyst comment in paragraph 7By Sahil  Pandey and Christy Santhosh. Compass Pathways CMPS.O said on Tuesday its psilocybin-based therapy eased depression symptoms in a late-stage trial, sending the drug developer's shares up nearly 42%, as it aims to win approval for the first classic psychedelic treatment in the United States.The therapy, COMP360, consists of a synthetic formulation of psilocybin, the active ingredient in \"magic mushrooms\". It is designed as a short-term, episodic alternative to daily antidepressants for patients with hard-to-treat and long-lasting depressive episodes.In the study, COMP006 involving 581 patients, two 25 milligram doses were given to patients three weeks ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nL4N3ZD0MY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2430703251.USD","LU1894683348.USD","IE0009355771.USD","LU0889566641.SGD","IE00B3T34201.USD","IE0034235303.USD","BK4533","IE00BBT3K403.USD","JNJ","LU0234572021.USD","LU0234570918.USD","LU0432979614.USD","LU1032466523.USD","LU0795875169.SGD","LU1244550494.USD","IE00BJT1NW94.SGD","LU1066051498.USD","LU0882574055.USD","IE00BSNM7G36.USD","LU2129689431.USD","LU2505996681.GBP","LU0098860793.USD","LU1267930813.SGD","LU0345769128.USD","CMPS","LU1032955483.USD","LU2430703095.HKD","LU1261432733.SGD","LU0795875086.SGD","LU0689626769.HKD","LU0320765646.SGD","LU2471134523.USD","LU0124676726.USD","LU1057294990.SGD","LU2089984988.USD","LU1244550577.SGD","LU1506573853.SGD","BK4585","IE00B19Z3B42.SGD","LU0345770993.USD","LU2505996509.AUD","LU0070217475.USD","BK4568","BK4532","LU1221951129.SGD","LU0345770308.USD","LU0203345920.USD","LU1914381329.SGD","LU0683600562.USD","IE00BLSP4239.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.compasspathways.com","stockEarnings":[{"period":"1week","weight":0.3391},{"period":"1month","weight":0.1497},{"period":"3month","weight":0.625},{"period":"6month","weight":0.833},{"period":"1year","weight":0.9074},{"period":"ytd","weight":0.2246}],"compareEarnings":[{"period":"1week","weight":-0.0082},{"period":"1month","weight":-0.0078},{"period":"3month","weight":0.0517},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1223},{"period":"ytd","weight":0.0064}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.053854},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.028794},{"month":3,"riseRate":0.2,"avgChangeRate":-0.109959},{"month":4,"riseRate":0.4,"avgChangeRate":-0.016443},{"month":5,"riseRate":0.4,"avgChangeRate":-0.043784},{"month":6,"riseRate":0.6,"avgChangeRate":-0.018137},{"month":7,"riseRate":0.8,"avgChangeRate":0.262657},{"month":8,"riseRate":0.4,"avgChangeRate":-0.005792},{"month":9,"riseRate":0.2,"avgChangeRate":-0.10118},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.009194},{"month":11,"riseRate":0.333333,"avgChangeRate":0.034765},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.01163}],"exchange":"NASDAQ","name":"COMPASS Pathways plc","nameEN":"COMPASS Pathways plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"COMPASS Pathways plc(CMPS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest COMPASS Pathways plc(CMPS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"COMPASS Pathways plc,CMPS,COMPASS Pathways plc股票,COMPASS Pathways plc股票老虎,COMPASS Pathways plc股票老虎国际,COMPASS Pathways plc行情,COMPASS Pathways plc股票行情,COMPASS Pathways plc股价,COMPASS Pathways plc股市,COMPASS Pathways plc股票价格,COMPASS Pathways plc股票交易,COMPASS Pathways plc股票购买,COMPASS Pathways plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"COMPASS Pathways plc(CMPS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest COMPASS Pathways plc(CMPS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}